Electrocardiographic Left Ventricular Hypertrophy
Academic Press Inc (Verlag)
978-0-443-33927-1 (ISBN)
This book recognizes and fulfills the urgent need to change the classical diagnostic paradigms of ECG diagnosis in LVH. To do so, it turns attention to so-called false-negative ECG findings that in truth provide valuable information that largely overlooked. When used to their fullest potential, these results can be used for enhanced diagnosis, selection of targeted therapy and cardiovascular risk assessment.
Ljuba Bacharová, MD, MBA, DSc, is the senior research leader at the International Laser Center CVTI, and a part-time teacher at both the Slovak Medical University and the Medical School at Comenius University in Bratislava (from which she received her medical degree). Following graduation, she dedicated herself to internal medicine and medical informatics. She went on to receive her MBA degree at the Business School at University of Leeds, UK. In 2011, she received a Doctor of Sciences (DSc) for her innovative approach to the ECG diagnosis of left ventricular hypertrophy. Her main research interest is the evaluation of the cardiac electric field, from standard 2-lead ECG to modeling, 3D visualization and multimodal imaging. In 2005 she became the executive editor of the Journal of Electrocardiology, and since 2006, she has spearheaded the International Research Interdisciplinary Schools (IRIS). Niraj Varma, MD, PhD, FRCP is Professor of Medicine at Cleveland Clinic, USA. After medical school in Oxford and Edinburgh, he received specialist training in Cambridge, UK and Harvard Medical School, USA. In Boston he undertook research work leading to a PhD. He has over 25 years of clinical experience maintaining research projects; e.g. pioneering the first clinical applications of remote monitoring of implantable devices, electrocardiographic imaging (ECGI), and cardiac resynchronization algorithms. His current interests are the effects of heart size (hypertrophy and shape) in heart failure on pacing therapies. He is past president of the International Society for Holter and Noninvasive Electrocardiology (ISHNE), currently serves on the Digital Health Committee of the Heart Rhythm Society (HRS), and is Deputy Editor of Europace journal.
1. Introduction
2. Electrocardiographic criteria for left ventricular hypertrophy diagnosis
3. ST segment strain pattern in left ventricular hypertrophy
4. QT interval dynamics in left ventricular hypertrophy
5. Epidemiology and prognosis of left ventricular hypertrophy through electrocardiography: from Minnesota Code to artificial intelligence
6. Echocardiographic diagnosis of left ventricular hypertrophy and its compatibility with electrocardiographic criteria: the “false negative and false positive” electrocardiography
7. Addition of serum biomarkers carboxyterminal propeptide of procollagen type I (PICP) and NT-proBNP levels to electrocardiography criteria for detection of left ventricular hypertrophyl
8. The discrepancy between wall thickness, myocardial mass, and ECG appearances in young patients with cardiomyopathies
9. Electrocardiographic and echocardiographic differences in the athlete’s heart: a special category
10. Electrocardiographic left ventricular hypertrophy and stroke
11. Evolving left ventricular hypertrophy: heart failure
12. How far should blood pressure be lowered in middle-aged and elderly patients with hypertension and ECG-LVH? Experiences from LIFE and VALUE
13. Surgical approaches in hypertrophic cardiomyopathy treatment
14. Genetic factors influencing clinical phenotype and electrocardiographic features in left ventricular hypertrophy
15. Artificial intelligence for detecting left ventricular hypertrophy using electrocardiography
16. Technical considerations in the automated ECG diagnosis of left ventricular hypertrophy
17. Myocardial hypertrophy and ischemia: mechanisms of electrophysiological abnormalities
18. Effect of volumetric and conductivity changes in the left ventricle on QRS complex morphology in simulations
19. The variety of QRS patterns in left ventricular hypertrophy and their electrophysiological interpretation
20. Increased LV mass, electrical remodeling, and surface ECG conduction abnormalities in heart failure: implications for implantable defibrillators and cardiac resynchronization therapy
| Erscheinungsdatum | 22.11.2025 |
|---|---|
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 191 x 235 mm |
| Gewicht | 450 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
| Naturwissenschaften ► Biologie | |
| ISBN-10 | 0-443-33927-9 / 0443339279 |
| ISBN-13 | 978-0-443-33927-1 / 9780443339271 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
